The stock of Invivyd Inc (IVVD) has seen a -7.14% decrease in the past week, with a 14.32% gain in the past month, and a -72.27% decrease in the past quarter. The volatility ratio for the week is 18.47%, and the volatility levels for the past 30 days are at 13.52% for IVVD. The simple moving average for the last 20 days is 1.01% for IVVD stock, with a simple moving average of -31.66% for the last 200 days.
Is It Worth Investing in Invivyd Inc (NASDAQ: IVVD) Right Now?
The 36-month beta value for IVVD is also noteworthy at 0.40. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 1 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
The public float for IVVD is 75.94M, and at present, short sellers hold a 9.24% of that float. The average trading volume of IVVD on May 08, 2025 was 3.93M shares.
IVVD) stock’s latest price update
The stock price of Invivyd Inc (NASDAQ: IVVD) has surged by 10.71 when compared to previous closing price of 0.53, but the company has seen a -7.14% decline in its stock price over the last five trading sessions. globenewswire.com reported 2025-04-21 that WALTHAM, Mass., April 21, 2025 (GLOBE NEWSWIRE) — Invivyd, Inc. (Nasdaq: IVVD), a biopharmaceutical company devoted to delivering protection from serious viral infectious diseases, today announced that it has signed a $30 million term loan facility with Silicon Valley Bank (SVB), a division of First Citizens Bank. The deal allows for drawdown of capital in the future if certain conditions and milestones are met.
Analysts’ Opinion of IVVD
Many brokerage firms have already submitted their reports for IVVD stocks, with Guggenheim repeating the rating for IVVD by listing it as a “Buy.” The predicted price for IVVD in the upcoming period, according to Guggenheim is $9 based on the research report published on April 05, 2024 of the previous year 2024.
Morgan Stanley, on the other hand, stated in their research note that they expect to see IVVD reach a price target of $10, previously predicting the price at $4. The rating they have provided for IVVD stocks is “Overweight” according to the report published on March 26th, 2024.
Morgan Stanley gave a rating of “Equal-Weight” to IVVD, setting the target price at $4 in the report published on December 19th of the previous year.
IVVD Trading at -17.12% from the 50-Day Moving Average
After a stumble in the market that brought IVVD to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -78.64% of loss for the given period.
Volatility was left at 13.52%, however, over the last 30 days, the volatility rate increased by 18.47%, as shares surge +17.04% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -54.98% lower at present.
During the last 5 trading sessions, IVVD fell by -7.14%, which changed the moving average for the period of 200-days by -49.11% in comparison to the 20-day moving average, which settled at $0.5793. In addition, Invivyd Inc saw 32.07% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IVVD starting from MCGUIRE TERRANCE, who sale 103,474 shares at the price of $0.45 back on Dec 31 ’24. After this action, MCGUIRE TERRANCE now owns 3,066,757 shares of Invivyd Inc, valued at $46,098 using the latest closing price.
MCGUIRE TERRANCE, the Director of Invivyd Inc, sale 83,744 shares at $0.52 during a trade that took place back on Dec 27 ’24, which means that MCGUIRE TERRANCE is holding 3,256,776 shares at $43,647 based on the most recent closing price.
Stock Fundamentals for IVVD
Current profitability levels for the company are sitting at:
- -6.97 for the present operating margin
- 0.92 for the gross margin
The net margin for Invivyd Inc stands at -6.69. The total capital return value is set at -2.62. Equity return is now at value -138.71, with -94.75 for asset returns.
Based on Invivyd Inc (IVVD), the company’s capital structure generated 0.02 points at debt to capital in total, while cash flow to debt ratio is standing at -130.74.
Currently, EBITDA for the company is -173.76 million with net debt to EBITDA at 0.39. When we switch over and look at the enterprise to sales, we see a ratio of 0.08. The receivables turnover for the company is 2.27for trailing twelve months and the total asset turnover is 0.2. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.62.
Conclusion
In summary, Invivyd Inc (IVVD) has had a mixed performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
